Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia

Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants...

Full description

Bibliographic Details
Main Authors: Claudio Nardiello, Ivana Mižíková, Diogo M. Silva, Jordi Ruiz-Camp, Konstantin Mayer, István Vadász, Susanne Herold, Werner Seeger, Rory E. Morty
Format: Article
Language:English
Published: The Company of Biologists 2017-02-01
Series:Disease Models & Mechanisms
Subjects:
BPD
Online Access:http://dmm.biologists.org/content/10/2/185
id doaj-84eef915f84248079459f5ccfa3ecf1d
record_format Article
spelling doaj-84eef915f84248079459f5ccfa3ecf1d2020-11-24T21:46:25ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112017-02-0110218519610.1242/dmm.027086027086Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasiaClaudio Nardiello0Ivana Mižíková1Diogo M. Silva2Jordi Ruiz-Camp3Konstantin Mayer4István Vadász5Susanne Herold6Werner Seeger7Rory E. Morty8 Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants with BPD. Newborn mouse pups were exposed to a varying fraction of oxygen in the inspired air (FiO2) and a varying window of hyperoxia exposure, after which lung structure was assessed by design-based stereology with systemic uniform random sampling. The efficacy of a candidate therapeutic intervention using parenteral nutrition was evaluated to demonstrate the utility of the standardised BPD model for drug discovery. An FiO2 of 0.85 for the first 14 days of life decreased total alveoli number and concomitantly increased alveolar septal wall thickness, which are two key histopathological characteristics of BPD. A reduction in FiO2 to 0.60 or 0.40 also caused a decrease in the total alveoli number, but the septal wall thickness was not impacted. Neither a decreasing oxygen gradient (from FiO2 0.85 to 0.21 over the first 14 days of life) nor an oscillation in FiO2 (between 0.85 and 0.40 on a 24 h:24 h cycle) had an appreciable impact on lung development. The risk of missing beneficial effects of therapeutic interventions at FiO2 0.85, using parenteral nutrition as an intervention in the model, was also noted, highlighting the utility of lower FiO2 in selected studies, and underscoring the need to tailor the model employed to the experimental intervention. Thus, a state-of-the-art BPD animal model that recapitulates the two histopathological hallmark perturbations to lung architecture associated with BPD is described. The model presented here, where injurious stimuli have been systematically evaluated, provides a most promising approach for the development of new strategies to drive postnatal lung maturation in affected infants.http://dmm.biologists.org/content/10/2/185BPDHyperoxiaAlveolarisationStructureAnimal model
collection DOAJ
language English
format Article
sources DOAJ
author Claudio Nardiello
Ivana Mižíková
Diogo M. Silva
Jordi Ruiz-Camp
Konstantin Mayer
István Vadász
Susanne Herold
Werner Seeger
Rory E. Morty
spellingShingle Claudio Nardiello
Ivana Mižíková
Diogo M. Silva
Jordi Ruiz-Camp
Konstantin Mayer
István Vadász
Susanne Herold
Werner Seeger
Rory E. Morty
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
Disease Models & Mechanisms
BPD
Hyperoxia
Alveolarisation
Structure
Animal model
author_facet Claudio Nardiello
Ivana Mižíková
Diogo M. Silva
Jordi Ruiz-Camp
Konstantin Mayer
István Vadász
Susanne Herold
Werner Seeger
Rory E. Morty
author_sort Claudio Nardiello
title Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
title_short Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
title_full Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
title_fullStr Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
title_full_unstemmed Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
title_sort standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2017-02-01
description Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants with BPD. Newborn mouse pups were exposed to a varying fraction of oxygen in the inspired air (FiO2) and a varying window of hyperoxia exposure, after which lung structure was assessed by design-based stereology with systemic uniform random sampling. The efficacy of a candidate therapeutic intervention using parenteral nutrition was evaluated to demonstrate the utility of the standardised BPD model for drug discovery. An FiO2 of 0.85 for the first 14 days of life decreased total alveoli number and concomitantly increased alveolar septal wall thickness, which are two key histopathological characteristics of BPD. A reduction in FiO2 to 0.60 or 0.40 also caused a decrease in the total alveoli number, but the septal wall thickness was not impacted. Neither a decreasing oxygen gradient (from FiO2 0.85 to 0.21 over the first 14 days of life) nor an oscillation in FiO2 (between 0.85 and 0.40 on a 24 h:24 h cycle) had an appreciable impact on lung development. The risk of missing beneficial effects of therapeutic interventions at FiO2 0.85, using parenteral nutrition as an intervention in the model, was also noted, highlighting the utility of lower FiO2 in selected studies, and underscoring the need to tailor the model employed to the experimental intervention. Thus, a state-of-the-art BPD animal model that recapitulates the two histopathological hallmark perturbations to lung architecture associated with BPD is described. The model presented here, where injurious stimuli have been systematically evaluated, provides a most promising approach for the development of new strategies to drive postnatal lung maturation in affected infants.
topic BPD
Hyperoxia
Alveolarisation
Structure
Animal model
url http://dmm.biologists.org/content/10/2/185
work_keys_str_mv AT claudionardiello standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT ivanamizikova standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT diogomsilva standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT jordiruizcamp standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT konstantinmayer standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT istvanvadasz standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT susanneherold standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT wernerseeger standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
AT roryemorty standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia
_version_ 1725902290358894592